Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of 4-Hydroxyethylpiperazineethanesulfonic Acid in Xanthine Oxidase Inhibiting Peptides

A technology of hydroxyethylpiperazine ethanesulfonic acid and xanthine oxidase, which can be applied to peptide/protein components, medical preparations containing active ingredients, drug combinations, etc. problem, to achieve the effect of enhancing the activity and improving the inhibition rate of xanthine oxidase

Active Publication Date: 2020-04-28
SOUTH CHINA UNIV OF TECH
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, existing drugs generally cannot cure hyperuricemia, and long-term use has serious side effects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of 4-Hydroxyethylpiperazineethanesulfonic Acid in Xanthine Oxidase Inhibiting Peptides
  • Application of 4-Hydroxyethylpiperazineethanesulfonic Acid in Xanthine Oxidase Inhibiting Peptides
  • Application of 4-Hydroxyethylpiperazineethanesulfonic Acid in Xanthine Oxidase Inhibiting Peptides

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0028] The enhancement effect of 4-hydroxyethylpiperazineethanesulfonic acid on tuna peptide xanthine oxidase inhibitors, the specific experimental steps are as follows:

[0029] (1) Prepare 150mM HEPES, Tris-HCl, PB buffer solution with pH value of 7.4 at 37°C, store at 4°C until use;

[0030] (2) Prepare the required sample (tuna peptide) with the above-mentioned 150mM buffer solution, and the sample concentration is 40mg / ml;

[0031] (3) Add 50 μL tuna peptide or 50 μL buffer (blank) and 150 μL xanthine to the 96-well ELISA plate in turn, make 3 parallels for each sample, add 50 μL xanthine oxidase after incubation at 37°C for 5 minutes, and read once every 30 seconds Absorbance value, a total of 50 times 25min. After reading, stop the reaction with 80 μL of HCl, take the reaction solution and dilute it 10 times with the corresponding buffer solution, pass it through a 0.25 μm water-based membrane, and measure the concentration of uric acid;

[0032] (4) high performance ...

Embodiment 2

[0039] The enhancement effect of 4-hydroxyethylpiperazineethanesulfonic acid on saury peptide xanthine oxidase inhibitor, the specific experimental steps are as follows:

[0040] (1) Prepare 150mM HEPES, Tris-HCl, PB buffer solution with pH value of 7.4 at 37°C, store at 4°C until use;

[0041] (2) Prepare the required sample (saury peptide) with the above-mentioned 150mM buffer solution, and the sample concentration is 40mg / ml;

[0042] (3) Add 50 μL saury peptide or 50 μL buffer solution (blank) and 150 μL xanthine to the 96-well ELISA plate in sequence, make 3 parallels for each sample, add 50 μL xanthine oxidase after incubation at 37°C for 5 minutes, and read for 30 seconds One absorbance value, a total of 50 times 25min. After reading, stop the reaction with 80 μL of HCl, take the reaction solution and dilute it 10 times with the corresponding buffer solution, pass it through a 0.25 μm water-based membrane, and measure the concentration of uric acid;

[0043] (4) high ...

Embodiment 3

[0050] The enhancement effect of 4-hydroxyethylpiperazineethanesulfonic acid on xanthine oxidase inhibitor of walnut meal protein peptide, the specific experimental steps are as follows:

[0051] (1) Prepare 150mM HEPES, Tris-HCl, PB buffer solution with pH value of 7.4 at 37°C, store at 4°C until use;

[0052] (2) Prepare the required sample (walnut meal protein peptide) with the above-mentioned 150mM buffer solution, and the sample concentration is 40mg / ml;

[0053] (3) Add 50 μL walnut meal protein peptide or 50 μL buffer solution (blank) and 150 μL xanthine to the 96-well ELISA plate in sequence, make 3 parallels for each sample, incubate at 37°C for 5 minutes, then add 50 μL xanthine oxidase for 30 seconds Read the absorbance value once, a total of 50 times for 25 minutes. After reading, stop the reaction with 80 μ LHCl, take the reaction solution and dilute it 10 times with the corresponding buffer solution, pass it through a 0.25 μm water-based membrane, and measure th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) in enhancing the activity of a xanthine oxidase inhibitory peptide. The xanthine oxidase inhibitorypeptide comprises peptides obtained through fermentation or protease enzymolysis of food-borne protein, preferably, tuna peptides, saury peptides and walnut meal protein peptides. Research finds thatHEPES has the remarkable function of enhancing the activity of polypeptide xanthine oxidase inhibitors, and the xanthine oxidase inhibitory peptide has the best polypeptide xanthine oxidase inhibiting function in an HEPES-containing buffer system as compared with that in conventional buffer systems (Tris-HCl) and PB (phosphate buffer) commonly used for screening of xanthine oxidase inhibitory activity.

Description

technical field [0001] The invention relates to a new application of 4-hydroxyethylpiperazineethanesulfonic acid (HEPES), in particular to the application of 4-hydroxyethylpiperazineethanesulfonic acid in enhancing the activity of xanthine oxidase inhibitory peptides. Background technique [0002] Uric acid is a product of the metabolism of purine substances in the human body. The content of uric acid in normal human blood is 200-410 μmol / L. Once uric acid is excessively formed and / or excreted less, it will cause the blood uric acid level to rise, thus causing uric acid Deposition of salt in soft tissues, which in turn induces hyperuricemia. [0003] In recent years, with the development of society, people's life and diet have changed. The tense pace of life and bad eating habits have led to more and more people suffering from hyperuricemia. It has become a disease following high blood pressure, high blood sugar, The "fourth highest" that seriously endangers human health af...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/495A61K38/00A61P43/00A61P19/06
Inventor 苏国万何伟炜赵谋明孙东晓
Owner SOUTH CHINA UNIV OF TECH